See also this year's filing and all EDGAR filings for this company.
PDF Report 0001157601_2021_Madrigal_Pharmaceuticals_INC.pdf
Logs
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 0.8942096935739066, 'aggregate_val': 391482000, 'exp_sum': 206673000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 21864000, 'ResearchAndDevelopmentExpense': 184809000, 'remainder_Expenses': 0}} |
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 0.8460999166948474, 'aggregate_val': 447646000, 'exp_sum': 242482000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 37318000, 'ResearchAndDevelopmentExpense': 205164000, 'remainder_Expenses': 0}} |
| warning | Expenses in unusual place in relation to revenue | input.sec.calculation_linkbase.edgar_model_mapping | {'expenses_node': 'OperatingExpenses', 'revenue_node': 'Revenues', 'net_inc_node': 'NetIncomeLoss'} |
Graph
Absolute values for 0001157601, Madrigal Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 285,163,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,047,000 |
| 3 | remainder_Assets | 785,000 |
| 4 | LiabilitiesCurrent | 46,557,000 |
| 5 | LiabilitiesNoncurrent | 468,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 21,886,910 |
| 9 | ResearchAndDevelopmentExpense | 252,184,353 |
| 10 | remainder_Expenses | 184,809,000 |
| 11 | remainder_Revenues | 46,972 |
| 12 | remainder_NetIncome | 4,001,082 |
| 13 | remainder_ComprehensiveNetIncome | -254,418 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 286,995,000 |
| 1 | Liabilities | 47,025,000 |
| 2 | Expenses | 458,880,263 |
| 3 | Revenues | 46,972 |
| 4 | StockholdersEquity | 239,970,000 |
| 5 | NetIncome | -454,832,209 |
| 6 | ComprehensiveNetIncome | -454,959,418 |
| 7 | BaseVar | 398,601,368 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.408 |
| 9 | EconomicCapitalRatio | 1.80 |